Cytori Reports Second Quarter 2015 Business and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Roth Capital Cuts Price Target on Cytori Therapeutics (CYTX) Following 2Q Earnings Report
August 10, 2015 7:56 AM EDTRoth Capital reiterated a Buy rating on Cytori Therapeutics, Inc. (NASDAQ: CYTX), and cut the price target to $4.00 (from $6.00), following the company's 2Q15 earnings release. EPS of $0.03 beat the consensus estimates of -$0.03. CYTX ended the quarter with $23.8 million in cash.
Analyst Joseph Pantginis... More
Cytori Therapeutics (CYTX) PT Trimmed to $5 at Maxim Group; 'Buy' Maintained
August 7, 2015 7:43 AM EDTMaxim Group analyst Jason Kolbert trimmed his price target on Cytori Therapeutics, Inc. (NASDAQ: CYTX) to $5.00 (from $7.00) following Q2 results but maintained his Buy rating.
The cut comes on a greater than expected share count.
The analyst highlighted the following Quarter Progress: STAR TRIAL, OA, Incontinence and Burns
Announced the launch of its US STAR trial, which is being considered a "pivotal"... MoreCytori Therapeutics (CYTX) Tops Q2 EPS by 6c
August 6, 2015 4:38 PM EDTCytori Therapeutics (NASDAQ: CYTX) reported Q2 EPS of $0.03, $0.06 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $1.61 million versus the consensus estimate of $2.5 million.
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
... More
